BIOMAT Database Logo BIOMAT Database Logo

Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin. 2001

R J Robbins, and R M Tuttle, and M Sonenberg, and A Shaha, and R Sharaf, and H Robbins, and M Fleisher, and S M Larson
Department of Medicine, Memorial Hospital for Cancer and Allied Diseases, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. robbinsr@mskcc.org

Radioiodine ablation (RA) of normal thyroid remnants after thyroidectomy for differentiated thyroid carcinoma improves the sensitivity of subsequent radioiodine scans and serum thyroglobulin measurements for detection of residual thyroid carcinoma. Local cancer recurrences are also lower after RA. One standard preparation for RA involves rendering the patient hypothyroid in order to stimulate endogenous thyrotropin (TSH) secretion and sodium iodide symporter (NIS) activity. An alternative approach is to prescribe thyroxine after thyroidectomy and to stimulate NIS with exogenous recombinant human thyrotropin (rhTSH). This latter approach was used in 10 patients at our medical center. Complete resolution of all visible 131I thyroid bed uptake was achieved in all when follow-up scans were performed 5 to 13 months later. This approach has the potential to successfully ablate thyroid remnants without the need to induce hypothyroidism.

UI MeSH Term Description Entries
D007457 Iodine Radioisotopes Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. Radioisotopes, Iodine
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011182 Postoperative Care The period of care beginning when the patient is removed from surgery and aimed at meeting the patient's psychological and physical needs directly after surgery. (From Dictionary of Health Services Management, 2d ed) Care, Postoperative,Postoperative Procedures,Procedures, Postoperative,Postoperative Procedure,Procedure, Postoperative
D011877 Radionuclide Imaging The production of an image obtained by cameras that detect the radioactive emissions of an injected radionuclide as it has distributed differentially throughout tissues in the body. The image obtained from a moving detector is called a scan, while the image obtained from a stationary camera device is called a scintiphotograph. Gamma Camera Imaging,Radioisotope Scanning,Scanning, Radioisotope,Scintigraphy,Scintiphotography,Imaging, Gamma Camera,Imaging, Radionuclide
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002277 Carcinoma A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for "cancer." Carcinoma, Anaplastic,Carcinoma, Spindle-Cell,Carcinoma, Undifferentiated,Carcinomatosis,Epithelial Neoplasms, Malignant,Epithelioma,Epithelial Tumors, Malignant,Malignant Epithelial Neoplasms,Neoplasms, Malignant Epithelial,Anaplastic Carcinoma,Anaplastic Carcinomas,Carcinoma, Spindle Cell,Carcinomas,Carcinomatoses,Epithelial Neoplasm, Malignant,Epithelial Tumor, Malignant,Epitheliomas,Malignant Epithelial Neoplasm,Malignant Epithelial Tumor,Malignant Epithelial Tumors,Neoplasm, Malignant Epithelial,Spindle-Cell Carcinoma,Spindle-Cell Carcinomas,Tumor, Malignant Epithelial,Undifferentiated Carcinoma,Undifferentiated Carcinomas
D002291 Carcinoma, Papillary A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. (Stedman, 25th ed) Carcinomas, Papillary,Papillary Carcinoma,Papillary Carcinomas
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R J Robbins, and R M Tuttle, and M Sonenberg, and A Shaha, and R Sharaf, and H Robbins, and M Fleisher, and S M Larson
Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study.
March 2006, The Journal of clinical endocrinology and metabolism,
R J Robbins, and R M Tuttle, and M Sonenberg, and A Shaha, and R Sharaf, and H Robbins, and M Fleisher, and S M Larson
Radioiodine ablation of post-surgical thyroid remnants after preparation with recombinant human TSH: why, how and when.
June 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
R J Robbins, and R M Tuttle, and M Sonenberg, and A Shaha, and R Sharaf, and H Robbins, and M Fleisher, and S M Larson
Follow-up of low-risk differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after either recombinant human thyrotropin or thyroid hormone withdrawal.
November 2009, The Journal of clinical endocrinology and metabolism,
R J Robbins, and R M Tuttle, and M Sonenberg, and A Shaha, and R Sharaf, and H Robbins, and M Fleisher, and S M Larson
Recombinant human thyroid-stimulating hormone is effective for radioiodine ablation of post-surgical thyroid remnants.
August 2006, Nuclear medicine communications,
R J Robbins, and R M Tuttle, and M Sonenberg, and A Shaha, and R Sharaf, and H Robbins, and M Fleisher, and S M Larson
Radioiodine thyroid remnant ablation after recombinant human thyrotropin or thyroid hormone withdrawal in patients with high-risk differentiated thyroid cancer.
January 2012, Journal of thyroid research,
R J Robbins, and R M Tuttle, and M Sonenberg, and A Shaha, and R Sharaf, and H Robbins, and M Fleisher, and S M Larson
Iodine biokinetics and radioiodine exposure after recombinant human thyrotropin-assisted remnant ablation in comparison with thyroid hormone withdrawal.
July 2010, The Journal of clinical endocrinology and metabolism,
R J Robbins, and R M Tuttle, and M Sonenberg, and A Shaha, and R Sharaf, and H Robbins, and M Fleisher, and S M Larson
Radioiodine Ablation of Thyroid Remnants in Patients with Graves' Orbitopathy.
April 2023, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
R J Robbins, and R M Tuttle, and M Sonenberg, and A Shaha, and R Sharaf, and H Robbins, and M Fleisher, and S M Larson
Recombinant human thyrotropin versus thyroid hormone withdrawal preparation for radioiodine ablation in differentiated thyroid cancer: Experience in a South Taiwanese medical center.
February 2023, The Kaohsiung journal of medical sciences,
R J Robbins, and R M Tuttle, and M Sonenberg, and A Shaha, and R Sharaf, and H Robbins, and M Fleisher, and S M Larson
Radioiodine treatment with 30 mCi after recombinant human thyrotropin stimulation in thyroid cancer: effectiveness for postsurgical remnants ablation and possible role of iodine content in L-thyroxine in the outcome of ablation.
September 2003, The Journal of clinical endocrinology and metabolism,
R J Robbins, and R M Tuttle, and M Sonenberg, and A Shaha, and R Sharaf, and H Robbins, and M Fleisher, and S M Larson
Recombinant human thyrotropin preparation for adjuvant radioiodine treatment in children and adolescents with differentiated thyroid cancer.
December 2015, European journal of endocrinology,
Copied contents to your clipboard!